Related Experiment Video

Updated: May 9, 2026

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

The duplicitous origin of ovarian cancer

Gil Mor1, Ayesha Alvero

  • 1Department of Obstetrics Gynecology and Reproductive Sciences, Reproductive Immunology Unit, Yale University School of Medicine, New Haven, CT, USA.

Rambam Maimonides Medical Journal
|August 3, 2013
PubMed

Insights

Ovarian cancer, a lethal gynecologic malignancy, lacks new treatments. This review explores ovarian cancer stem cells

Area of Science:

  • Gynecologic Oncology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Ovarian cancer remains the most lethal gynecologic malignancy, with no significant therapeutic advances since the 1990s.
  • Late-stage detection and chemotherapy resistance contribute to poor outcomes.
  • The cellular origin and heterogeneity of ovarian tumors are not well understood.

Purpose of the Study:

  • To review the role of ovarian cancer stem cells (OCSCs) in tumor formation and recurrence.
  • To highlight the complexity and hierarchical organization of ovarian tumors.
  • To advocate for a paradigm shift in understanding ovarian cancer's diverse cellular origins.

Main Methods:

  • Literature review focusing on ovarian cancer stem cells.
  • Analysis of current understanding of ovarian tumor heterogeneity.
  • Discussion of the tumor microenvironment's role in ovarian cancer development.

Main Results:

  • Ovarian cancer stem cells play a critical role in tumor initiation and relapse.
  • Ovarian tumors are characterized by significant heterogeneity and hierarchical structures.
  • The unique microenvironment of the ovaries may facilitate metastasis from other primary sites.

Conclusions:

  • Rethinking ovarian cancer as a single entity with a uniform origin is necessary.
  • Understanding OCSCs and tumor complexity is crucial for developing novel therapeutic strategies.
  • A shift towards personalized or targeted therapies based on cellular origin and heterogeneity is needed.
Keywords:
Ovarian cancercancer markerscancer stem cellschemotherapy

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...